Dobutamine/dopamine/milrinoneLack of efficacy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1755卷 / 1期

关键词：

D O I：

10.1007/s40278-019-62686-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：132 / 132

相关论文

共 50 条

[21] MilrinoneLack of efficacy: case report
[J]. Reactions Weekly, 2025, 2063 (1) : 193 - 193
[22] Dobutamine/Heparin/MilrinoneLack of efficacy and thrombocytopenia
[J]. Reactions Weekly, 2024, 2014 (1) : 238 - 238
[23] Esmolol/milrinoneLack of efficacy: case report
[J]. Reactions Weekly, 2020, 1827 (1) : 142 - 142
[24] Imatinib/milrinoneLack of efficacy : case report
[J]. Reactions Weekly, 2024, 2021 (1) : 245 - 245
[25] Furosemide/milrinoneLack of efficacy: case report
[J]. Reactions Weekly, 2021, 1839 (1) : 145 - 145
[26] Epoprostenol/milrinoneLack of efficacy: case report
[J]. Reactions Weekly, 2025, 2050 (1) : 226 - 226
[27] Dobutamine/dopamine/epinephrineLack of efficacy in hypotension: case report
[J]. Reactions Weekly, 2020, 1795 (1) : 110 - 110
[28] Epinephrine/MilrinoneLack of efficacy : case report
[J]. Reactions Weekly, 2024, 2019 (1) : 181 - 181
[29] Epoprostenol/milrinoneLack of efficacy: case report
[J]. Reactions Weekly, 2022, 1925 (1) : 240 - 240
[30] Dopamine/dobutamine/norepinephrineLack of efficacy: case report.
[J]. Reactions Weekly, 2020, 1835 (1) : 143 - 143

← 1 2 3 4 5 →